First vaccine to protect older adults from respiratory syncytial virus (RSV) infection

View source ↗

Summary

The European Medicines Agency announces the first vaccine approved to protect older adults from Respiratory Syncytial Virus (RSV) infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection